Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors

Figure 3

Disease-free survival curves after radical surgical resection at diagnosis according to grading (a), p-mTOR QS (b), IGF-1R (c), and SSTR2A (d).

(a)

(b)

(c)

(d)